SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 160 filers reported holding SYNDAX PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,883,000 | -30.6% | 1,025,000 | 0.0% | 6.13% | -41.6% |
| Q2 2023 | $21,453,250 | -0.9% | 1,025,000 | 0.0% | 10.51% | +0.9% |
| Q1 2023 | $21,648,000 | -17.0% | 1,025,000 | 0.0% | 10.42% | -39.5% |
| Q4 2022 | $26,086,250 | +5.9% | 1,025,000 | 0.0% | 17.22% | +5.3% |
| Q3 2022 | $24,631,000 | +24.9% | 1,025,000 | 0.0% | 16.36% | +16.2% |
| Q2 2022 | $19,721,000 | +10.7% | 1,025,000 | 0.0% | 14.07% | +46.3% |
| Q1 2022 | $17,815,000 | -20.6% | 1,025,000 | 0.0% | 9.61% | +21.5% |
| Q4 2021 | $22,437,000 | +14.5% | 1,025,000 | 0.0% | 7.92% | +102.7% |
| Q3 2021 | $19,588,000 | +11.3% | 1,025,000 | 0.0% | 3.91% | +38.6% |
| Q2 2021 | $17,599,000 | -23.2% | 1,025,000 | 0.0% | 2.82% | -31.7% |
| Q1 2021 | $22,919,000 | +0.5% | 1,025,000 | 0.0% | 4.12% | +5.4% |
| Q4 2020 | $22,796,000 | +50.7% | 1,025,000 | 0.0% | 3.92% | -19.0% |
| Q3 2020 | $15,129,000 | -0.4% | 1,025,000 | 0.0% | 4.83% | -16.6% |
| Q2 2020 | $15,191,000 | +58.3% | 1,025,000 | +17.1% | 5.80% | +38.6% |
| Q1 2020 | $9,599,000 | – | 875,000 | – | 4.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,025,000 | $21,648,000 | 10.42% |
| Foresite Capital Management IV, LLC | 875,000 | $18,480,000 | 9.59% |
| Kynam Capital Management, LP | 3,205,986 | $67,710,424 | 8.74% |
| Frazier Life Sciences Management, L.P. | 3,708,838 | $78,330,659 | 5.67% |
| ACUTA CAPITAL PARTNERS, LLC | 330,000 | $6,969,600 | 5.13% |
| Paradigm Biocapital Advisors LP | 2,274,512 | $48,037,693 | 4.55% |
| Eversept Partners, LP | 2,209,057 | $46,655,284 | 3.25% |
| DAFNA Capital Management LLC | 447,073 | $9,442,182 | 2.83% |
| COMMODORE CAPITAL LP | 853,884 | $18,034,030 | 2.75% |
| Avidity Partners Management LP | 3,865,300 | $81,635,136 | 2.71% |